Conversely, when overexpressed, SCD is involved in metabolic diseases such as diabetes and NAFLD, by regulating the canonical Wnt pathway through the activation of β-catenin and the consequent activation of hepatic stellate cells (HSCs), which support liver cell degeneration [36,37]. The gene discussed is SCD; the disease is diabetes mellitus.